Prion (PrP) antibody and antigen (Recombinant protein)

Diagnostic antibodies (anti-Prion, anti-PrP) and antigens (recombinant protein) for Infectious disease PrP detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Infectious disease diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg) First Order Discount First Order Discount Price
GMP-IVD-P045-Tg001-Ag01 Recombinant human Prion PrP Protein 3090
GMP-IVD-P045-Tg001-Ab01 Anti-human Prion PrP mouse monoclonal antibody (mAb) 1953 20% 1562.4
GMP-IVD-P045-Tg001-Ab02 Anti-human Prion PrP mouse monoclonal antibody (mAb) 1953 20% 1562.4
GMP-IVD-P045-Tg001-Ab03 Anti-human Prion PrP human monoclonal antibody (mAb) 1953 20% 1562.4
GMP-IVD-P045-Tg001-Ab04 Anti-human Prion PrP human monoclonal antibody (mAb) 1953 20% 1562.4

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-IVD-P045-Tg001-Ag01
Product Name Recombinant human Prion PrP Protein
Pathogen Prion
Target/Biomarker PrP
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation (PrP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PrP level test of Infectious disease (Transmissible spongiform encephalopathies) and related syndrome evaluation.
Tag His
Products description Recombinant human Prion PrP Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-IVD-P045-Tg001-Ab01, GMP-IVD-P045-Tg001-Ab02
Product Name Anti-human Prion PrP mouse monoclonal antibody (mAb)
Pathogen Prion
Target/Biomarker PrP
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation (PrP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PrP level test of Infectious disease (Transmissible spongiform encephalopathies) and related syndrome evaluation.
Tag mFc
Products description Anti-human Prion PrP mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-IVD-P045-Tg001-Ab03, GMP-IVD-P045-Tg001-Ab04
Product Name Anti-human Prion PrP human monoclonal antibody (mAb)
Pathogen Prion
Target/Biomarker PrP
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation (PrP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PrP level test of Infectious disease (Transmissible spongiform encephalopathies) and related syndrome evaluation.
Tag hFc
Products description Anti-human Prion PrP human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Prion diseases, also known as transmissible spongiform encephalopathies or TSEs, are a group of rare, fatal brain diseases that affect animals and humans. They are caused by an infectious agent known as a prion, which is derived from a misfolded version of a normal host protein known as prion protein



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    Michael Williams 2023-09-20 05:32:02
    It can be concluded that the SPA antibody has higher stability and data quality for Lateral Flow Immunoassay (LFIA). It is useful in improving the specificity of diagnosis.

    Leave a comment